CI Global Health Sciences Corporate Class

Series A USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date July 1996
Total net assets ($CAD)
As at 2023-04-28
$154.8 million
NAVPS
As at 2023-06-07
$36.6986
MER (%)
As at 2022-09-30
2.34
Management fee (%) 1.90
Asset class Sector Equity
Currency USD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.7240

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

A ISC 301
DSC SO* 401
LL SO 1401
F 324
P 90324
Y 4926
Z ISC 2926
DSC 2927
LL 2929
*No new purchases directly into switch only funds.

Performance2 As at 2023-05-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
-0.90% -3.27% 3.18% -2.25% -0.28% 1.86% 1.77% 3.28% 7.78%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.7240
2021-03-26 0.2492
2020-12-18 0.3973
2020-09-25 0.3778
2020-06-26 0.2765
Payable date Total
2020-03-20 0.6464
2019-12-13 0.4049
2019-09-27 0.4529
2019-06-21 0.4275
2019-03-22 0.6736

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series A USD
 
Portfolio allocations4 As at 2023-04-30
Asset allocation (%)
  • US Equity 72.84
  • International Equity 26.28
  • Cash and Equivalents 0.91
  • Other -0.03
Sector allocation (%)
  • Healthcare 93.79
  • Exchange Traded Fund 3.38
  • Consumer Services 1.95
  • Cash and Cash Equivalent 0.91
  • Other -0.03
Geographic allocation(%)
  • United States 73.69
  • United Kingdom 7.90
  • Switzerland 5.68
  • Denmark 5.13
  • Australia 2.35
  • Ireland 2.09
  • Germany 1.77
  • Belgium 1.38
  • Canada 0.04
  • Other -0.03
Top holdings
Sector (%)
1. UnitedHealth Group Inc Healthcare Services 6.93%
2. Johnson & Johnson Drugs 5.95%
3. Eli Lilly and Co Drugs 5.91%
4. AstraZeneca PLC Drugs 5.90%
5. Merck & Co Inc Drugs 5.35%
6. Novo Nordisk A/S Cl B Drugs 5.13%
7. Humana Inc Healthcare Services 4.59%
8. Thermo Fisher Scientific Inc Healthcare Equipment 4.08%
9. Zoetis Inc Cl A Drugs 3.87%
10. SPDR S&P Biotech ETF (XBI) Exchange Traded Fund 3.38%
11. Amgen Inc Drugs 3.24%
12. Edwards Lifesciences Corp Healthcare Equipment 3.06%
13. Stryker Corp Healthcare Equipment 2.99%
14. Danaher Corp Healthcare Equipment 2.61%
15. CSL Ltd Drugs 2.35%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.